Interleukin 1 signaling occurs exclusively via the type I receptor
about
Cloning and characterization of a new isoform of the interleukin 1 receptor antagonistMolecular cloning and characterization of a second subunit of the interleukin 1 receptor complexSoluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonistResistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memoryOsteoimmunology: interactions of the bone and immune systemKeratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammationIntracellular IL-1alpha-binding proteins contribute to biological functions of endogenous IL-1alpha in systemic sclerosis fibroblastsThe type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptorThe interleukin 1 (IL-1) system in the uteroplacental complex of a cartilaginous fish, the smoothhound shark, Mustelus canisIL-1 receptor 2 (IL-1R2) and its role in immune regulationLymphocytic 2',5'-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccineHIV-1 coat protein gp120 stimulates interleukin-1beta secretion from human neuroblastoma cells: evidence for a role in the mechanism of cell deathIdentification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signalingAnti-inflammatory properties of a novel peptide interleukin 1 receptor antagonistMacrophage sub-populations and the lipoxin A4 receptor implicate active inflammation during equine tendon repairMurine P-glycoprotein deficiency alters intestinal injury repair and blunts lipopolysaccharide-induced radioprotection.Sleep-wake behavior and responses to sleep deprivation of mice lacking both interleukin-1 beta receptor 1 and tumor necrosis factor-alpha receptor 1.Hemolytically active (acylated) alpha-hemolysin elicits interleukin-1beta (IL-1beta) but augments the lethality of Escherichia coli by an IL-1- and tumor necrosis factor-independent mechanism.Cloning and characterization of the rainbow trout (Oncorhynchus mykiss) type II interleukin-1 receptor cDNA.Mouse cloned from embryonic stem (ES) cells synchronized in metaphase with nocodazole.Three Promoters Regulate Tissue- and Cell Type-specific Expression of Murine Interleukin-1 Receptor Type I.Soluble cytokine receptors: basic immunology and clinical applications.Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response.The IL-1 receptor and Rho directly associate to drive cell activation in inflammation.Leptin regulation of proangiogenic molecules in benign and cancerous endometrial cells.Central IL-1 receptor signaling regulates bone growth and massInterleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide.Soluble cytokine receptors: novel immunotherapeutic agents.Contribution of interleukin-11 and prostaglandin(s) in lipopolysaccharide-induced bone resorption in vivo.Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture.T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family.Cloning and characterization of an alternatively processed human type II interleukin-1 receptor mRNA.Invited review: cytokine regulation of fever: studies using gene knockout mice.Soluble cytokine receptors in biological therapy.Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist.MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs.IL-1 beta signalling in glial cells in wildtype and IL-1RI deficient micePerspective of cytokine regulation for periodontal treatment: fibroblast biology.Interleukin 1 type 1 receptor restore: a genetic mouse model for studying interleukin 1 receptor-mediated effects in specific cell typesInterleukin-1 (IL-1)-induced resistance to bacterial infection: role of the type I IL-1 receptor.
P2860
Q24321369-54E6CC49-48E9-4351-9285-5D56FF6C60E8Q24321703-124F5098-C5E1-4F9B-9735-B0E07AC101CFQ24563274-51F7EC61-0D74-484E-A73C-B13B1689825AQ24647760-E8D53E4A-4328-4140-9136-9EE1B09E82FCQ24655113-D7F57024-5ECD-4155-A807-3726370F11EBQ24673428-3193D646-75C7-41AB-8398-5A079B9F51D4Q24676706-33B30E86-9FF7-4C14-BA0B-4B6138CA1DA4Q24680185-4D4AD71C-0437-455B-9A69-3DBE5DD19C84Q24806149-D3920193-EA27-4E17-B456-01E64E0B58BEQ26826872-9C356292-129F-49B2-9362-5F0CBE4FBD17Q27477782-3F813F36-47DD-42AD-AE81-9F92A855B72DQ28363800-D17CA08A-ADCF-4425-A542-7BF616D8DD44Q28592094-BFA8E0AA-A3F2-4102-A379-100EB4746F29Q28659160-929EED50-4F46-4F5B-A504-8CDC3C0CAA06Q28731852-03038F17-88B1-47EA-BE69-2F9D092DF2DCQ30417497-5CBF980F-9093-4AEE-B772-6C4165B1AA0FQ30430842-029EC368-8F8F-4CEA-8C77-04EDC2F8D71DQ30453726-69704572-31F9-4C32-9A5B-0B67418DE8ABQ30975538-EBC34F18-71D1-46D9-AAA1-B0A1F68C843FQ31909883-FC960832-9701-4B27-879D-3B57B664622CQ33406063-7D57147A-2710-4A00-8CB6-1F1B3226683CQ33688222-CF6F6A73-9A6E-4B6B-90BC-54FA9CB90C0EQ33770974-87BD5CA3-25A7-4F55-A37F-E6966B2C0319Q33852530-4553C8F6-E98F-48C2-951F-0E557CA65158Q33941240-1E45C42F-2CC4-4CB2-A944-1BF2372E58AFQ33943828-440065BF-1E05-4521-8C96-0BB2898C43F2Q34001542-09148A44-E0BF-43C8-9BA5-6AC77C0C2261Q34074749-590C1E21-88A8-402C-A085-319EAFA01AA5Q34126507-B6425F36-3CCC-45A7-94A9-3A87255AB853Q34223350-6941C53A-DD07-4863-9BE4-33C454CD06C9Q34377979-E340C9DB-0A08-45AF-873A-73E2594257E7Q34388642-7D4160D6-ADDB-4B0D-886B-4D372457DE56Q34641692-26C6AF8C-6380-4EFC-BB80-FACA10174D96Q34779777-AEC1CBF7-C1B3-4C72-AD48-3231C77F17DAQ34900183-5CD6DAEC-9F34-498A-AA38-4BC9BEE070FFQ34985576-A286BB7D-74A9-486A-ABD1-ECD504D95949Q35044365-BD508593-071D-4DA0-89B4-025B163A8402Q35068825-7611F2A9-E655-409A-A437-8A851FEE42BDQ35092662-60BE8EF3-B510-4085-B6E5-1D2D1CE27627Q35117155-E7E3A208-74EB-45A1-88E3-2D03F679BABC
P2860
Interleukin 1 signaling occurs exclusively via the type I receptor
description
1993 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 1993
@ast
im Juli 1993 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1993/07/01)
@sk
vědecký článek publikovaný v roce 1993
@cs
wetenschappelijk artikel (gepubliceerd op 1993/07/01)
@nl
наукова стаття, опублікована в липні 1993
@uk
name
Interleukin 1 signaling occurs exclusively via the type I receptor
@ast
Interleukin 1 signaling occurs exclusively via the type I receptor
@en
Interleukin 1 signaling occurs exclusively via the type I receptor
@nl
type
label
Interleukin 1 signaling occurs exclusively via the type I receptor
@ast
Interleukin 1 signaling occurs exclusively via the type I receptor
@en
Interleukin 1 signaling occurs exclusively via the type I receptor
@nl
prefLabel
Interleukin 1 signaling occurs exclusively via the type I receptor
@ast
Interleukin 1 signaling occurs exclusively via the type I receptor
@en
Interleukin 1 signaling occurs exclusively via the type I receptor
@nl
P2093
P2860
P3181
P356
P1476
Interleukin 1 signaling occurs exclusively via the type I receptor
@en
P2093
F. Colotta
J. E. Sims
J. G. Giri
J. L. Slack
K. Shanebeck
M. A. Gayle
M. R. Alderson
T. A. Bird
P2860
P304
P3181
P356
10.1073/PNAS.90.13.6155
P407
P577
1993-07-01T00:00:00Z